IndustryPayments
Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

HEATHER SUSAN ROSDAIL

Physician Assistants & Advanced Practice Nursing Providers Nurse Practitioner Psychiatric/Mental Health

NPI
1407578537
CMS profile
11413908
Location
ROSEVILLE, CA

General Payments · PY2022–2024

$4,476.71

  • Reported across 78 records
  • CMS publication 2026-01-23

Latest program year · PY2024

$2,162.53

51 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

Related groups: Psychiatric/Mental Health CA All categories

By nature of payment

PY2024 · sorted by reported total

Nature of paymentAmountRecords
Food and Beverage $2,162.53 51

By paying entity

PY2024 · sorted by reported total

Paying entityAmountRecords
Janssen Pharmaceuticals, Inc $923.45 17
ITI, Inc. $280.00 8
Alnylam Pharmaceuticals Inc. $243.70 2
ABBVIE INC. $148.50 8
Alkermes, Inc. $131.61 5
Teva Pharmaceuticals USA, Inc. $125.00 1
Gilead Sciences, Inc. $114.53 1
Otsuka America Pharmaceutical, Inc. $99.90 5
E.R. Squibb & Sons, L.L.C. $28.71 1
Janssen Scientific Affairs, LLC $24.27 1
Axsome Therapeutics, Inc. $23.50 1
Indivior Inc. $19.36 1

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2022 $289.33 3
PY2023 $2,024.85 24
PY2024 $2,162.53 51

Payment records · PY2024 (51)

Sorted by paying entity, then date · as published by CMS

Program year 2024 20222023 Record-level detail is published for PY2024; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
ABBVIE INC. $7.71 08/22/2024 Food and Beverage Undisputed 01/23/2026 1108112758 CMS
ABBVIE INC. $20.74 08/29/2024 Food and Beverage Undisputed 01/23/2026 1108112760 CMS
ABBVIE INC. $13.23 09/04/2024 Food and Beverage Undisputed 01/23/2026 1108112762 CMS
ABBVIE INC. $32.60 09/23/2024 Food and Beverage Undisputed 01/23/2026 1108112764 CMS
ABBVIE INC. $17.98 10/21/2024 Food and Beverage Undisputed 01/23/2026 1108112766 CMS
ABBVIE INC. $13.90 11/08/2024 Food and Beverage Undisputed 01/23/2026 1108112768 CMS
ABBVIE INC. $29.06 12/10/2024 Food and Beverage Undisputed 01/23/2026 1108112770 CMS
ABBVIE INC. $13.28 12/12/2024 Food and Beverage Undisputed 01/23/2026 1108112772 CMS
Alkermes, Inc. $23.68 07/09/2024 Food and Beverage Undisputed 01/23/2026 1120584124 CMS
Alkermes, Inc. $13.27 08/07/2024 Food and Beverage Undisputed 01/23/2026 1120584126 CMS
Alkermes, Inc. $33.95 10/22/2024 Food and Beverage Undisputed 01/23/2026 1120584128 CMS
Alkermes, Inc. $30.00 11/27/2024 Food and Beverage Undisputed 01/23/2026 1120584130 CMS
Alkermes, Inc. $30.71 12/16/2024 Food and Beverage Undisputed 01/23/2026 1120584132 CMS
Alnylam Pharmaceuticals Inc. $121.86 01/10/2024 Food and Beverage Undisputed 01/23/2026 1125855651 CMS
Alnylam Pharmaceuticals Inc. $121.84 05/08/2024 Food and Beverage Undisputed 01/23/2026 1125855653 CMS
Axsome Therapeutics, Inc. $23.50 06/12/2024 Food and Beverage Undisputed 01/23/2026 1148362690 CMS
E.R. Squibb & Sons, L.L.C. $28.71 11/19/2024 Food and Beverage Undisputed 01/23/2026 1101293937 CMS
Gilead Sciences, Inc. $114.53 07/10/2024 Food and Beverage Undisputed 01/23/2026 1133702482 CMS
Indivior Inc. $19.36 06/27/2024 Food and Beverage Undisputed 01/23/2026 1144569418 CMS
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $125.00 05/16/2024 Food and Beverage Undisputed 01/23/2026 1143592260 CMS
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $21.24 05/23/2024 Food and Beverage Undisputed 01/23/2026 1143592262 CMS
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $27.69 08/20/2024 Food and Beverage Undisputed 01/23/2026 1143592264 CMS
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $25.55 10/02/2024 Food and Beverage Undisputed 01/23/2026 1143592266 CMS
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $27.25 10/24/2024 Food and Beverage Undisputed 01/23/2026 1143592268 CMS
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $13.91 11/12/2024 Food and Beverage Undisputed 01/23/2026 1143592270 CMS
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $21.63 11/18/2024 Food and Beverage Undisputed 01/23/2026 1143592272 CMS
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $17.73 12/09/2024 Food and Beverage Undisputed 01/23/2026 1143592274 CMS
Janssen Pharmaceuticals, Inc $99.01 02/07/2024 Food and Beverage Undisputed 01/23/2026 1077936836 CMS
Janssen Pharmaceuticals, Inc $32.74 04/22/2024 Food and Beverage Undisputed 01/23/2026 1077936962 CMS
Janssen Pharmaceuticals, Inc $132.23 05/02/2024 Food and Beverage Undisputed 01/23/2026 1077936928 CMS
Janssen Pharmaceuticals, Inc $40.77 06/05/2024 Food and Beverage Undisputed 01/23/2026 1077936838 CMS
Janssen Pharmaceuticals, Inc $19.32 06/10/2024 Food and Beverage Undisputed 01/23/2026 1077936892 CMS
Janssen Pharmaceuticals, Inc $80.67 06/19/2024 Food and Beverage Undisputed 01/23/2026 1077936998 CMS
Janssen Pharmaceuticals, Inc $93.85 06/26/2024 Food and Beverage Undisputed 01/23/2026 1077936940 CMS
Janssen Pharmaceuticals, Inc $32.95 08/12/2024 Food and Beverage Undisputed 01/23/2026 1077936968 CMS
Janssen Pharmaceuticals, Inc $26.52 09/03/2024 Food and Beverage Undisputed 01/23/2026 1077936954 CMS
Janssen Pharmaceuticals, Inc $8.11 09/26/2024 Food and Beverage Undisputed 01/23/2026 1077936816 CMS
Janssen Pharmaceuticals, Inc $70.00 09/26/2024 Food and Beverage Undisputed 01/23/2026 1077936930 CMS
Janssen Pharmaceuticals, Inc $30.44 10/16/2024 Food and Beverage Undisputed 01/23/2026 1077936938 CMS
Janssen Pharmaceuticals, Inc $17.32 10/17/2024 Food and Beverage Undisputed 01/23/2026 1077936852 CMS
Janssen Pharmaceuticals, Inc $22.29 11/11/2024 Food and Beverage Undisputed 01/23/2026 1077936914 CMS
Janssen Pharmaceuticals, Inc $95.85 11/12/2024 Food and Beverage Undisputed 01/23/2026 1077936948 CMS
Janssen Pharmaceuticals, Inc $109.54 11/20/2024 Food and Beverage Undisputed 01/23/2026 1077937018 CMS
Janssen Pharmaceuticals, Inc $11.84 12/02/2024 Food and Beverage Undisputed 01/23/2026 1077937014 CMS
Janssen Scientific Affairs, LLC $24.27 06/19/2024 Food and Beverage Undisputed 01/23/2026 1078845555 CMS
Otsuka America Pharmaceutical, Inc. $15.08 04/25/2024 Food and Beverage Undisputed 01/23/2026 1119175190 CMS
Otsuka America Pharmaceutical, Inc. $15.54 06/25/2024 Food and Beverage Undisputed 01/23/2026 1119175192 CMS
Otsuka America Pharmaceutical, Inc. $20.91 08/15/2024 Food and Beverage Undisputed 01/23/2026 1119175194 CMS
Otsuka America Pharmaceutical, Inc. $21.66 09/16/2024 Food and Beverage Undisputed 01/23/2026 1119175196 CMS
Otsuka America Pharmaceutical, Inc. $26.71 09/30/2024 Food and Beverage Undisputed 01/23/2026 1119175198 CMS
Teva Pharmaceuticals USA, Inc. $125.00 03/06/2024 Food and Beverage Undisputed 01/23/2026 1151703317 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2022, 2023, 2024
Source files
Dataset page · Bulk file · PY2022 , PY2023 , PY2024
Generated from
OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.